Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Glucose-lowering Drugs
100%
Qatar
100%
Diabetes Subgroups
100%
Severe Insulin Resistance
75%
β-cell Function
75%
Hemoglobin A1c (HbA1c)
50%
Insulin Sensitivity
50%
Insulin Deficiency
50%
Therapeutic Change
25%
Cluster Analysis
25%
Body Mass Index
25%
Glycated Hemoglobin A1c
25%
High Body Mass Index
25%
Differential Response
25%
Metformin
25%
Glucose-insulin System
25%
Type 2 Diabetic Patients
25%
Very Severe
25%
Plasma Glucose
25%
Glucose Control
25%
Oral Glucose Tolerance Test
25%
Combination Therapy
25%
Cluster Group
25%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
25%
Insulin Sensitizers
25%
Insulin Secretion
25%
Hyperinsulinemia
25%
Insulin Therapy
25%
Type 2 Diabetes Mellitus Patients
25%
Metabolic Phenotype
25%
C-peptide
25%
Basal Insulin
25%
Pioglitazone
25%
Peptide Concentration
25%
Cluster Response
25%
Exenatide
25%
Insulin Peptides
25%
Glipizide
25%
Insulin Clearance
25%
Initial Combination Therapy
25%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Insulin Resistance
60%
Cell Function
60%
Hemoglobin A1c
60%
Beta Cell
60%
Body Mass Index
40%
Combination Therapy
40%
Homeostatic Model Assessment
40%
Insulin Sensitivity
40%
Insulin Deficiency
40%
Cluster Analysis
20%
Drug Therapy
20%
Glycon
20%
Research Design
20%
Glycated Hemoglobin
20%
Oral Glucose Tolerance Test
20%
Patient with Type 2 Diabetes
20%
Insulin Release
20%
Hyperinsulinemia
20%
Insulin Treatment
20%
C-Peptide
20%
Pioglitazone
20%
Insulin Sensitizing Agent
20%
Exenatide
20%
Insulin Clearance
20%
Glipizide
20%
Biochemistry, Genetics and Molecular Biology
Insulin Resistance
100%
Cell Function
75%
Body Mass
50%
Insulin Sensitivity
50%
Cluster Analysis
25%
Glucose Blood Level
25%
Glycated Hemoglobin
25%
Insulin Release
25%
C-Peptide
25%
Sensitization
25%
Glucose Test
25%
Glucose Tolerance Test
25%
Pioglitazone
25%
Glipizide
25%
Insulin Clearance
25%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Insulin Resistance
80%
Hemoglobin A1c
60%
Combination Therapy
40%
Insulin Deficiency
40%
Metformin
20%
Glycosylated Hemoglobin
20%
C Peptide
20%
Insulin Sensitizing Agent
20%
Pioglitazone
20%
Hyperinsulinemia
20%
Glipizide
20%
Exendin 4
20%